Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

Technology appraisal guidance
Reference number: TA668
Published: 06 January 2021

Evidence

Supporting evidence

Evaluation report
Appraisal consultation committee papers (PDF 3.87 MB)

Published:

06 January 2021
Final appraisal determination committee papers (PDF 1.63 MB)

Published:

06 January 2021